2005
DOI: 10.1111/j.1365-2710.2005.00664.x
|View full text |Cite
|
Sign up to set email alerts
|

A second (non-genomic) steroid mechanism of action: possible opportunity for novel pharmacotherapy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 61 publications
(74 reference statements)
0
1
0
Order By: Relevance
“…13,14 SHBG regulate androgen action and reversible with high affinity to androgens in circulation (DHT, testosterone, 3α-androstenediol) and estrogen with lower affinity. 13,15 In older men, increased of SHBG levels followed by decreased of FT levels, but TT levels did not change. 16 Study result shows that low levels of SHBG and testosterone in the circulation associated with metabolic syndrome.…”
Section: Introductionmentioning
confidence: 99%
“…13,14 SHBG regulate androgen action and reversible with high affinity to androgens in circulation (DHT, testosterone, 3α-androstenediol) and estrogen with lower affinity. 13,15 In older men, increased of SHBG levels followed by decreased of FT levels, but TT levels did not change. 16 Study result shows that low levels of SHBG and testosterone in the circulation associated with metabolic syndrome.…”
Section: Introductionmentioning
confidence: 99%